POPULARITY
82 episodes with mitral
30 episodes with mitral
13 episodes with mitral
12 episodes with mitral
9 episodes with mitral
5 episodes with mitral
9 episodes with mitral
10 episodes with mitral
5 episodes with mitral
92 episodes with mitral
4 episodes with mitral
5 episodes with mitral
5 episodes with mitral
4 episodes with mitral
5 episodes with mitral
3 episodes with mitral
3 episodes with mitral
3 episodes with mitral
7 episodes with mitral
3 episodes with mitral
5 episodes with mitral
4 episodes with mitral
3 episodes with mitral
2 episodes with mitral
2 episodes with mitral
2 episodes with mitral
3 episodes with mitral
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826261438351
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826261424812
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826261453799
This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Isaac George, CTSNet Board Member and Co-Director of the Structural Heart and Valve Center, Surgical Director of Structural Heart Disease, and Co-Director of the Mitral and Tricuspid Center at Columbia University Medical Center/NewYork-Presbyterian, NY, USA, about the lifetime management of aortic valve disease. Chapters 00:00 Intro 02:11 AATS-CTSN Randomized Trials 04:37 JANS 1, Consensus Statement ALAD 10:28 JANS 2, Lung Re-Transplantation Outcomes 12:19 JANS 3, Aortic Homografts, EURECAH 15:15 JANS 4, Lobectomy Cost Analysis 18:10 Video 1, Anomalous L Coronary Artery 19:38 Video 2, Pulm Valve Replacement Reop 21:38 Video 3, Giant Pulm Artery Aneurysm 23:28 Dr. George Discussion 33:18 Upcoming Events 34:05 Closing They explored the expansion of transcatheter aortic valve replacement (TAVR), emphasizing the crucial role of the heart valve team in this process. The discussion highlighted the necessity for surgeons to be actively involved in the decision-making process surrounding TAVR, particularly in the early stages. They also addressed the importance of lifetime management of the valve, selecting the appropriate valve, and valve durability. Additionally, they discussed the significance of providing patients with multiple surgical options, the Ross procedure, mechanical valves, and explored which procedures patients are choosing. Joel also highlights recent JANS articles on the ISHLT consensus statement on acute lung allograft dysfunction, aortic homografts for native and prosthetic aortic valve and root endocarditis, how outcomes after lung re-transplantation for restrictive allograft syndrome have not improved over two decades, and the financial burden of postoperative adverse events following lobectomy. In addition, Joel explores the surgical repair of an anomalous left coronary artery from the right pulmonary artery, minimally invasive pulmonary valve replacement in reoperative settings, and surgical management of giant pulmonary artery aneurysm using a T-shaped graft-valve strategy. Before closing, Joel highlights upcoming events in CT surgery. JANS Items Mentioned ISHLT Consensus Statement on Acute Lung Allograft Dysfunction (ALAD): Definition, Etiology, Diagnostic and Therapeutic Approaches, and Research Priorities Aortic Homografts for Native and Prosthetic Aortic Valve and Root Endocarditis: Results From the EUropean REgistry of Cryopreserved Aortic Homografts EURECAH Outcomes After Lung Re-Transplantation for Restrictive Allograft Syndrome Have Not Improved Over Two Decades Financial Burden of Postoperative Adverse Events Following Lobectomy: Cost Analysis From 10 High-Volume Canadian Hospitals CTSNet Content Mentioned Surgical Repair of an Anomalous Left Coronary Artery From the Right Pulmonary Artery Minimally Invasive Pulmonary Valve Replacement in Reoperative Settings Surgical Management of Giant Pulmonary Artery Aneurysm Using a T-Shaped Graft-Valve Strategy Other Items Mentioned CTSNet Innovation Video Competition Career Center CTSNet Events Disclaimer The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.
Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on Audiovisual Distraction During Mitral Transcatheter Edge-to-Edge Repair: A Sedation-Sparing Randomized Trial.
Commentary by Dr. Kevin Kam.
Commentary by Dr. Jian'an Wang.
In this episode, host Alyssa Watson, DVM, welcomes Thomas K. Day, DVM, MS, DACVAA (Emeritus), DACVECC (Emeritus), CVA, Cert. IVUSS, to discuss his recent Clinician's Brief article, “Anesthesia for Dental Surgery in a Dog With Myxomatous Mitral Valve Disease.” With his broad background in anesthesia and critical care, Dr. Day shares a wealth of useful information for handling these challenging anesthetic cases. You will want to keep your notebook close to take notes on everything from drug selection to dosing to even fluid dosing. Resources: https://www.cliniciansbrief.com/article/mmvd-dental-anesthesia-quiz https://www.apoquel.com Contact: podcast@instinct.vet Where To Find Us: Website: CliniciansBrief.com/Podcasts YouTube: Youtube.com/@clinicians_brief Facebook: Facebook.com/CliniciansBrief LinkedIn: LinkedIn.com/showcase/CliniciansBrief/ Instagram: @Clinicians.Brief X: @CliniciansBrief The Team: Alyssa Watson, DVM - Host Alexis Ussery - Producer & Multimedia Specialist
Philippe Pouletty, M.D., CEO of Truffle Capital and Founder of Carvolix, describes the evolution of heart valve replacement and the significance of AI-guided robotics in expanding access to transcatheter procedures. The company's biomimetic mitral valve and AI software that guides valve placement using a mini robot are making these procedures safer and easier for less experienced cardiologists to perform. The technology is also being adapted to treat brain strokes by enabling a larger pool of cardiologists to quickly perform necessary interventions. Philippe explains, "At Truffle Capital, are what we like to call ourselves Business Builders, which is to say we're not just going to start small companies, we are going to try and build world leaders to revolutionize medicine. For Carvolix, this means interventional cardiology as well as the treatment of brain strokes. As you know, replacing heart valves is a major medical need. We have four heart valves that open and close 50 to 100 times per minute, which can get calcified and dysfunctional with time and need replacement. So 40 years ago, you would go to a skilled surgeon who would say, "Okay, I'm going to open your chest. I'm going to stop your heart, and I'm going to sew a new valve." "But recently we decided to lead the new revolution, which is a small robot based on artificial intelligence, that could autonomously, under the clinical supervision of a cardiologist, replace a valve. We think that this new revolution is going to allow many more patients to benefit from aortic, mitral, and tricuspid valve replacement, even in smaller cardiac centers and among younger cardiologists. A similar revolution happened in the cockpit of Boeing and Airbus planes when the autopilot, the GPS systems, and satellite systems brought autonomy to planes." #Carvolix #CardiacNews #PatientCare #HealthTech #Cardio #AIinHealthcare #InterventionalCardiology #StrokeCare #MedTechInnovation #RoboticsInMedicine #TAVI #Thrombectomy #DigitalHealth Carvolix.eu Download the transcript here
Philippe Pouletty, M.D., CEO of Truffle Capital and Founder of Carvolix, describes the evolution of heart valve replacement and the significance of AI-guided robotics in expanding access to transcatheter procedures. The company's biomimetic mitral valve and AI software that guides valve placement using a mini robot are making these procedures safer and easier for less experienced cardiologists to perform. The technology is also being adapted to treat brain strokes by enabling a larger pool of cardiologists to quickly perform necessary interventions. Philippe explains, "At Truffle Capital, are what we like to call ourselves Business Builders, which is to say we're not just going to start small companies, we are going to try and build world leaders to revolutionize medicine. For Carvolix, this means interventional cardiology as well as the treatment of brain strokes. As you know, replacing heart valves is a major medical need. We have four heart valves that open and close 50 to 100 times per minute, which can get calcified and dysfunctional with time and need replacement. So 40 years ago, you would go to a skilled surgeon who would say, "Okay, I'm going to open your chest. I'm going to stop your heart, and I'm going to sew a new valve." "But recently we decided to lead the new revolution, which is a small robot based on artificial intelligence, that could autonomously, under the clinical supervision of a cardiologist, replace a valve. We think that this new revolution is going to allow many more patients to benefit from aortic, mitral, and tricuspid valve replacement, even in smaller cardiac centers and among younger cardiologists. A similar revolution happened in the cockpit of Boeing and Airbus planes when the autopilot, the GPS systems, and satellite systems brought autonomy to planes." #Carvolix #CardiacNews #PatientCare #HealthTech #Cardio #AIinHealthcare #InterventionalCardiology #StrokeCare #MedTechInnovation #RoboticsInMedicine #TAVI #Thrombectomy #DigitalHealth Carvolix.eu Listen to the podcast here
In this episode, we review the high-yield topic of Mitral Regurgitation from the Cardiovascular section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
LBCT: Outcomes Of Patients Who Were Ineligible for Transcatheter Mitral Valve Replacement Trials: Insight from a Multicenter Registry
This episode covers: Cardiology This Week: A concise summary of recent studies The heart in high altitude Mitral annular disjunction Mythbusters: Weekend mortality Host: Rick Grobbee Guests: JP Carpenter, Kristina Haugaa, Silvia Ulrich Want to watch that episode? Go to: https://esc365.escardio.org/event/2563 Want to watch that extended interview on mitral annular disjonction, go to: https://esc365.escardio.org/event/2563?resource=interview Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa, Nicolle Kraenkel and Silvia Ulrich have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
Host: Rick Grobbee Guest: Kristina Haugaa Want to watch that extended interview on https://esc365.escardio.org/event/2563?resource=interview Go to: Want to watch that episode? Go to: https://esc365.escardio.org/event/2563 Disclaimer ESC TV Today is supported by Novartis through an independent funding. The programme has not been influenced in any way by its funding partner. This programme is intended for health care professionals only and is to be used for educational purposes. The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices. Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC. All declarations of interest are listed at the end of the episode. The ESC is not liable for any translated content of this video. The English language always prevails. ESC TV Today uses a range of tools and resources (including AI) to support content production. All content is reviewed and approved by the editorial team. Statements and opinions expressed by guest speakers are their own. Declarations of interests Stephan Achenbach, Yasmina Bououdina, Rick Grobbee, Kristina Haugaa and Nicolle Kraenkel have declared to have no potential conflicts of interest to report. Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, AbbVie, Alnylam, Amgen, AstraZeneca, Bayer, BiAL, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, GSK, Lilly, Novartis, Novo Nordisk, Pfizer, Sanofi, Servier, Takeda, Tecnimede, Viatris. John-Paul Carpenter has declared to have potential conflicts of interest to report: stockholder MyCardium AI. Davide Capodanno has declared to have potential conflicts of interest to report: Abbott Vascular, Bristol Myers Squibb, Daiichi Sankyo, Edwards Lifesciences, Novo Nordisk, Sanofi Aventis, Terumo. David Duncker has declared to have potential conflicts of interest to report: lecture honoraria from Abbott, Astra Zeneca, Biotronik, Boehringer Ingelheim, Boston Scientifics, Bristol Meyers Squibb, CVRx, Daiichi Sankyo, Medtronic, Microport, Pfizer, Sanofi, Zoll. Konstantinos Koskinas has declared to have potential conflicts of interest to report: honoraria from MSD, Daiichi Sankyo, Sanofi. Felix Mahfoud has declared to have potential conflicts of interest to report: research grants from Deutsche Forschungsgemeinschaft (SFB TRR219), Deutsche Gesellschaft für Kardiologie (DGK), Deutsche Herzstiftung, Ablative Solutions, ReCor Medical. Consulting fees, payment honoraria lectures, presentations, speaker, support travel costs: Ablative Solutions, Astra-Zeneca, Novartis, Inari, Recor Medical, Medtronic, Philips, Merck. Steffen Petersen has declared to have potential conflicts of interest to report: consultancy for Circle Cardiovascular Imaging Inc. Calgary, Alberta, Canada. Emma Svennberg has declared to have potential conflicts of interest to report: Abbott, Astra Zeneca, Bayer, Bristol-Myers, Squibb-Pfizer, Johnson & Johnson.
No Click Valvar de hoje temos grandes insights sobre qual a melhor opção: Valve-in-Valve mitral ou Cirurgia de Retroca Valvar.
VetFolio - Veterinary Practice Management and Continuing Education Podcasts
The most common canine heart condition, myxomatous mitral valve disease (MMVD) starts quietly, with a faint heart murmur signaling the patient has a leaky mitral valve. Join board-certified veterinary cardiologist Dr. Whit Church for an interactive, live VetFolio Voice podcast discussion on the evaluation and management of canine heart disease. Dr. Church will explore practical strategies and emerging considerations for MMVD in dogs. This session provides a unique opportunity to hear directly from a specialist and gain real-world perspectives on improving patient outcomes.
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826261425223
Commentary by Dr. Jian'an Wang.
Commentary by Dr. Jian'an Wang.
How did a simple stitch transform mitral valve repair? In this episode, we spotlight the pioneers of cardiothoracic surgery, Ottavio Alfieri and Francesco Maisano - the minds behind the edge-to-edge repair. They revisit the early 1990s, when mitral repair was complex and inconsistent, and share how the now-famous Alfieri stitch—inspired by a congenital double-orifice valve—offered a simple, reliable solution. From early skepticism to global adoption and the rise of transcatheter therapies like MitraClip, this conversation traces how one elegant idea reshaped mitral valve treatment and continues to influence the future of structural heart therapy.
Dr Aaysha Cader, Social media editor for JACC Interventions discusses the paper, Transcatheter Edge-to-Edge Repair for SAM-Related Mitral Regurgitation in Patients With HCM: The TRANSPARENT Registry, with Professor Luca Testa.
In this episode, we review the high-yield topic of Mitral Stenosis from the Cardiovascular section at Medbullets.comFollow Medbullets on social media:Facebook: www.facebook.com/medbulletsInstagram: www.instagram.com/medbulletsofficialTwitter: www.twitter.com/medbulletsLinkedin: https://www.linkedin.com/company/medbullets
Two heart surgeons looked at the same heart and gave me opposite advice. One said plan surgery. The other said wait.At 42, in the best shape of my life, I was diagnosed with mitral valve prolapse with severe regurgitation. And suddenly I had to answer a question I never expected to face:
I never thought heart disease would be part of my story. At 42, in the best shape of my life, I was diagnosed with mitral valve prolapse and severe regurgitation. What started as a strange episode during a workout turned into months of fear, waiting, uncertainty, and eventually heart surgery. This is Part 1 of My Heart Story. In this episode of Anatomy of a Leader, I share what it was really like to be diagnosed with a heart condition at 42 — from early symptoms and medical tests to the emotional impact of living with uncertainty while raising young children and running a business. This is the beginning of a deeper series about fear, vulnerability, healing, and what happens when your body forces you to slow down and listen.This is not medical advice. This is my real story — shared in the hope that it helps someone feel less alone, recognise symptoms earlier, or feel brave enough to get checked.In this episode I talk about: – Mitral valve prolapse diagnosis – Heart palpitations and symptoms – ECG and echocardiogram experience – Waiting for cardiology appointments – Anxiety and fear after diagnosis – Exercising with a heart condition – Women's heart health being underdiagnosed – Why “being strong” can make illness lonelier00:00 Thought Heart Disease Was an Old Man's Problem00:51 I Was Physically Fit & Healthy01:20 The Workout That Changed Everything01:56 Why I Nearly Ignored The Symptoms03:14 Going To The GP03:45 ECG Referral & Experience06:11 Echo Referral & Experience 09:03 Hearing “Mitral Valve Prolapse”09:50 Waiting, Fear & Not Knowing13:00 Anxiety vs Heart Condition13:23 Tachycardia, A&E & Health System14:21 Symptoms of Mitral Valve Prolapse 16:12 Exercise Regularly & Monitor17:49 Exercising With A Heart Condition18:39 Loss Of Control & Trust20:38 Women's Heart Health Being Missed23:10 What I Wish I'd Known25:15 If You're Ignoring Symptoms — Please ListenFollow Maria Hvorostovsky:IG: https://www.instagram.com/anatomyofaleader/IG: https://www.instagram.com/mariahvorostovsky/LinkedIn: https://www.linkedin.com/in/mariahvo/TikTok: https://www.tiktok.com/@mariahvorostovsky/Website: https://www.anatomyofaleader.com/Artwork and video by https://www.londonbeautyphotographer.com/If you're living with a heart condition, supporting someone who is, or ignoring symptoms because life feels too busy — this episode is for you.
In today's VETgirl online veterinary continuing education podcast, we review a recent paper by Kurogochi et al entitled “Long-Term Outcomes of Mitral Valve Repair with Artificial Chordae and Annuloplasty for Myxomatous Mitral Valve Disease in Dogs”, published in the Journal of Veterinary Internal Medicine in 2025. Now, you're unlikely to be doing heart surgery on your myxomatous mitral valve disease (MMVD) patients, but this study is important for you to know about! After all, there ARE surgical options out there!
In today's VETgirl online veterinary continuing education podcast, we review a recent paper by Kurogochi et al entitled “Long-Term Outcomes of Mitral Valve Repair with Artificial Chordae and Annuloplasty for Myxomatous Mitral Valve Disease in Dogs”, published in the Journal of Veterinary Internal Medicine in 2025. Now, you're unlikely to be doing heart surgery on your myxomatous mitral valve disease (MMVD) patients, but this study is important for you to know about! After all, there ARE surgical options out there!
Join Digital Education Committee Chair and podcast host Michael S. Lloyd, MD, FHRS, and his guests Kelvin C. Chua, MBBS, MD, FHRS, CEPS-A, and Rahul N Doshi, MD, FHRS, for this week's Lead episode, which was recorded live at APHRS 2025 in Kyoto, Japan. This discussion will review recent evidence on the feasibility and safety of pulsed field ablation (PFA) for coronary sinus and left atrial appendage isolation, as well as mitral isthmus ablation, focusing on both acute and chronic outcomes. Panelists will examine procedural considerations, lesion durability, and safety signals highlighted in the study, and explore how these findings may inform evolving ablation strategies for complex atrial arrhythmias. Learning Objectives Summarize the acute and chronic feasibility and safety outcomes of pulsed field ablation (PFA) for coronary sinus isolation, left atrial appendage isolation, and mitral isthmus ablation as reported in the study. Evaluate procedural techniques and lesion durability considerations associated with using PFA in anatomically complex atrial structures. Assess the potential clinical implications of these findings for incorporating PFA into ablation strategies for complex atrial arrhythmias, including patient selection and risk mitigation. Podcast Contributors Michael S. Lloyd, MD, FHRS Kelvin C. Chua, MBBS, MD, FHRS, CEPS-A Rahul N Doshi, MD, FHRS Host and Contributor Disclosure(s): K.C. Chua•Nothing to disclose. R. N. Doshi•Speaking/Teaching/Consulting/Authoring: Boston Scientific, Kestra Inc., Abbott, Impulse Dynamics USA M. S. Lloyd •Honoraria/Speaking/Consulting: Medtronic, Agra MedTech, Circa Scientific •Membership on Advisory Committees: Boston Scientific Article for Discussion
Commentary by Dr. Jian'an Wang.
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251393909
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251396933
Interview with Ankur Kalra, MD
Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis
This week we review the topic of mitral annular disjunction ("MAD") and the possible association with ventricular arrhythmia or sudden death in the connective tissue disease patient. Is there a 'cut off' distance above which patients deserve more significant arrhythmia surveillance? What is the best way to measure the MAD distance? Can patients with low MAD distances have lower degrees or even no arrhythmic surveillance? How often should this distance be measured on CMR and can an echo measurement provide similar data? Dr. Daniel Castellanos, the first author of this work and Assistant Professor of Pediatrics at Harvard Medical School shares his deep insights this week.DOI: 10.1016/j.jocmr.2025.101954
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251347539
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826241313425
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251344846
Read the article here: https://journals.sagepub.com/doi/full/10.1177/30494826251362814
Insuficiência mitral pós-IAM: diferenciar ruptura de tethering é vital by Cardiopapers
A new era for complex mitral regurgitation. The ENCIRCLE pivotal trial in The Lancet reports that fully percutaneous, transfemoral, transseptal TMVR (SAPIEN M3) achieved durable MR reduction (≈96% ≤1+ at 1 year), low early mortality, and meaningful improvement in symptoms and quality of life for patients unsuitable for surgery or TEER. A third pathway for mitral disease is emerging—one built on precision access, valve-in-valve durability planning, and advancing patient selection. Innovation meeting clinical need.
We've got a three-peat favorite back on the mic—Dr. Karl Jandrey, DVM, DACVECC, emergency & critical care specialist at UC Davis School of Veterinary Medicine. In this “Ask the Vet” deep dive, Dr. Jandrey breaks down how heart disease shows up in pets, what to watch for at home, and what your vet does first in the ER.You'll learn the stealth early signs in dogs (like true exercise intolerance vs. stubbornness), when coughing and increased breathing effort mean “go now,” and why small breeds often face mitral valve disease while large breeds are at risk for dilated cardiomyopathy (including the grain-free/taurine connection). We also cover arrhythmias (like AFib) and dramatic collapses, the core ER toolkit (oxygen, ultrasound, diuretics), and practical home monitoring (why ≤30 breaths/min at rest matters).For cats, Dr. Jandrey explains hypertrophic cardiomyopathy (HCM)—why it's so hard to spot, the realities of sudden distress or clots (ATE), and what treatment and prognosis can look like. Plus: a quick detour into exciting oncology advances (hello, Lola the Golden Retriever!) and a feel-good moment with Dr. Jandrey's lab, Danson, a veteran blood donor.Send us your questions for a future Ask the Vet!Highlights / What You'll Learn:- Early, often-missed signs of cardiac disease in dogs- Mitral valve disease vs. dilated cardiomyopathy—who's at risk and why- ER playbook: oxygen, Lasix (furosemide), rhythm control, point-of-care ultrasound- Home check: how to count resting respiratory rate and what numbers matter- Cats & HCM: silent disease, clots, emergency steps, and tough decisions- Meds 101: pimobendan, digoxin, diuretics—where they fit- Diet note: taurine and the grain-free discussionWe also briefly discuss:pet heart disease, dog coughing heart, resting respiratory rate dog, dilated cardiomyopathy dogs, mitral valve disease small dogs, hypertrophic cardiomyopathy cats, cat blood clot back legs, veterinary ER, pimobendan for dogs, taurine deficiency grain-freehttps://www.vetmed.ucdavis.edu/faculty/karl-e-jandrey--What started during the COVID-19 lockdown with one baby gorilla at the Cleveland Zoo has grown into a channel loved by animal fans around the world. I'm a one-person operation—filming, editing, narrating, and sharing the most heartfelt moments of baby gorillas, orangutans, elephants, and other zoo animals. Whether it's Jameela's emotional journey or Clementine's first steps, each video brings you closer to the animals and their stories. If you love watching real animal behavior, learning fun facts, and supporting conservation through storytelling—this is your place! Subscribe to Larry's Animal Safari on YouTube @larrysanimalsafari ---Support our sponsor for this episode Blue Buffalo by visiting bluebuffalo.com. BLUE Natural Veterinary Diet formulas offer the natural alternative in nutritional therapy. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents.---All footage is owned by SLA Video Productions.
We've got a three-peat favorite back on the mic—Dr. Karl Jandrey, DVM, DACVECC, emergency & critical care specialist at UC Davis School of Veterinary Medicine. In this “Ask the Vet” deep dive, Dr. Jandrey breaks down how heart disease shows up in pets, what to watch for at home, and what your vet does first in the ER.You'll learn the stealth early signs in dogs (like true exercise intolerance vs. stubbornness), when coughing and increased breathing effort mean “go now,” and why small breeds often face mitral valve disease while large breeds are at risk for dilated cardiomyopathy (including the grain-free/taurine connection). We also cover arrhythmias (like AFib) and dramatic collapses, the core ER toolkit (oxygen, ultrasound, diuretics), and practical home monitoring (why ≤30 breaths/min at rest matters).For cats, Dr. Jandrey explains hypertrophic cardiomyopathy (HCM)—why it's so hard to spot, the realities of sudden distress or clots (ATE), and what treatment and prognosis can look like. Plus: a quick detour into exciting oncology advances (hello, Lola the Golden Retriever!) and a feel-good moment with Dr. Jandrey's lab, Danson, a veteran blood donor.Send us your questions for a future Ask the Vet!Highlights / What You'll Learn:- Early, often-missed signs of cardiac disease in dogs- Mitral valve disease vs. dilated cardiomyopathy—who's at risk and why- ER playbook: oxygen, Lasix (furosemide), rhythm control, point-of-care ultrasound- Home check: how to count resting respiratory rate and what numbers matter- Cats & HCM: silent disease, clots, emergency steps, and tough decisions- Meds 101: pimobendan, digoxin, diuretics—where they fit- Diet note: taurine and the grain-free discussionWe also briefly discuss:pet heart disease, dog coughing heart, resting respiratory rate dog, dilated cardiomyopathy dogs, mitral valve disease small dogs, hypertrophic cardiomyopathy cats, cat blood clot back legs, veterinary ER, pimobendan for dogs, taurine deficiency grain-freehttps://www.vetmed.ucdavis.edu/faculty/karl-e-jandrey--What started during the COVID-19 lockdown with one baby gorilla at the Cleveland Zoo has grown into a channel loved by animal fans around the world. I'm a one-person operation—filming, editing, narrating, and sharing the most heartfelt moments of baby gorillas, orangutans, elephants, and other zoo animals. Whether it's Jameela's emotional journey or Clementine's first steps, each video brings you closer to the animals and their stories. If you love watching real animal behavior, learning fun facts, and supporting conservation through storytelling—this is your place! Subscribe to Larry's Animal Safari on YouTube @larrysanimalsafari ---Support our sponsor for this episode Blue Buffalo by visiting bluebuffalo.com. BLUE Natural Veterinary Diet formulas offer the natural alternative in nutritional therapy. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents. At Blue Buffalo, we have an in-house Research & Development (R&D) team with over 300 years' experience in well-pet and veterinary therapeutic diets, over 600 scientific publications, and over 50 U.S. patents.---All footage is owned by SLA Video Productions.
#Cardiologia #AfyaCardio #AtualizaçãoMédica Nesse podcast, o Dr. José Roberto fala sobre Como manejar uma insuficiência mitral na emergência Gostou do conteúdo? Compartilhe este vídeo com seus colegas médicos! Aqui você encontra conteúdos atualizados, diretos ao ponto e focados em quem vive a Medicina na prática.
A 17 yo male presents for follow up on a “fainting” episode that occurred during football practice at the end of a running exercise. He states, “I do not know what happened. We finished a set of running sprints and next thing I knew, I was on the ground.” He denies injury from the event and history of prior episodes. His physical examination reveals a crescendo-decrescendo systolic murmur heart best at the apex, increasing in intensity with position change from supine to standing position. This most likely represents: A. Mitral regurgitation B. Physiologic murmur C. Hypertrophic cardiomyopathyD. Aortic stenosis Visit fhea.com to learn more!
Estenose Mitral descompensada, como manejar? by Cardiopapers
When an unexpected heart murmur shows up, you may not have a specialist on speed dial, but you can have their advice in your back pocket. In this episode of the Partner Podcast, cardiologists John Bonagura and Theresa DeFrancesco share real-world advice on how to detect, stage, and manage myxomatous mitral valve disease. Listen in for practical strategies to deploy the next time you're faced with the unexpected on the other end of the stethoscope. Sponsored by Boehringer IngelheimContact us:Podcast@instinct.vetWhere to find us:Website: CliniciansBrief.com/PodcastsYouTube: Youtube.com/@clinicians_briefFacebook: Facebook.com/CliniciansBriefLinkedIn: LinkedIn.com/showcase/CliniciansBrief/X: @cliniciansbriefInstagram: @clinicians.brief The Team:Beth Molleson, DVM - HostSarah Pate - Producer & Project Manager, Brief StudioTaylor Argo - Podcast Production & Sound Editing
In this episode of the Family Pet Podcast, hosts Michael and Stephen Shirley interview veterinary cardiologist Dr. Eric Owens, Cardiology DVM | DACVIM. They discuss various aspects of pet heart health. They explore common heart diseases in pets, including mitral valve disease in small dogs and dilated cardiomyopathy in large breeds. Dr. Owens shares insights on surgical interventions, the importance of early detection, and tips for maintaining heart health in pets. The conversation also touches on the emotional aspects of heart health, including the phenomenon of broken heart syndrome in humans.Keywordspet health, veterinary cardiology, heart disease, pet care, pet surgery, mitral valve disease, dilated cardiomyopathy, hypertrophic cardiomyopathy, pet heart health, veterinary specialistTakeawaysThe more you know about pet healthcare, the better pet parent you can be.Pet Heart Month is celebrated in February.Common cardiac surgeries are often performed on young dogs with congenital heart diseases.Without treatment, certain heart conditions can be fatal for pets.Mitral valve disease is the most common heart disease in small dogs.Dilated cardiomyopathy primarily affects large and giant breed dogs.Hypertrophic cardiomyopathy is a significant concern in cats.Monitoring breathing and signs of distress is crucial for pet heart health.Early detection of heart disease can lead to better outcomes for pets.Broken heart syndrome in humans is known as Takotsubo cardiomyopathy.
Send us a textSt. Luke's cardiologist Dr. Nidhi Madan joins Dr. Arnold on today's episode to discuss mitral valve conditions and how they are treated with MitraClip. To learn more about heart care services at St. Luke's, visit unitypoint.org/cr-heart.Do you have a question about a trending medical topic? Ask Dr. Arnold! Submit your question and it may be answered by Dr. Arnold on the podcast! Submit your questions at: https://www.unitypoint.org/cedarrapids/submit-a-question-for-the-mailbag.aspxIf you have a topic you'd like Dr. Arnold to discuss with a guest on the podcast, shoot us an email at stlukescr@unitypoint.org.
Message our hosts, Kieran and Jose.Season 3 of The Animal Heartbeat is all about the Veterinary Cardiology Icons - those who walk among us as legends of the veterinary cardiology world.This episode features Professor Chris Orton of Colorado State University. Prof Orton has been a leader in the field of canine heart surgery for over thirty years, having worked to develop both open heart surgery techniques on cardiopulmonary bypass and minimally invasive techniques to treat valve disease. Chris is known as a cardiologist and a surgeon, but also has a strong bench-top research background, evaluating the mitral valve and the mechanisms of degenerative disease.Join our hosts, Jose and Kieran, as they discuss Prof Orton's research experience and his experience over the last 3-years of trans-catheter edge-to-edge mitral valve repair, patient considerations and outcomes.
© 2020-2026 Ivy Podcast Discovery LLC
